Shvoong Home > Medicine & Health > Serum drug concentration in patients treated with various aminophylline regimens Summary

.

Serum drug concentration in patients treated with various aminophylline regimens Article Abstract

Abstract by : TsingHua
Visits : 9  words: 300   Published: February 28, 1999
This abstract was translated from 氨茶碱不同给药方案的血药浓度比较
OBJECTIVE:To compare the serum drug concentration,efficacy and toxic or side reactions of different aminophylline therapeutic regimens in patients with asthma.METHODS:102 patients were divided into oral,intravenous and oral plus intravenous administration groups.The samples of venous blood were collected at various time points after the administration of aminophylline.Then,the serum drug concentration was determined by HPLC.RESULTS:(1)in the oral group,87 percent of the patients with the regimen of 0.2 g q8h and 65 percent of those with the regimen of 0.2 g tid kept their bottom peak concentration among 10~20 μg·ml -1 respectively.(2)78 percent of patients with the regimen of 0.5 g iv drip qd and 82 percent of those with the regimen of 0.25 iv drip qd plus 0.1 g tid kept their bottom peak concentration among 10~20 μg·ml -1 respectively.(3)93 percent of the patients with the regimen of 0.1 g tid and 82 percent of those with the regimen of 0.2 g qn kept their bottom concentration under 10 μg·ml -1 .Serum drug concentration of 3 cases with the toxic effects was more than 20 μg·ml -1 .CONCLUSIONS:For treatment and prevention of mild or medial asthma relative low dosage of aminophylline ( 0.1 tid or 0.2 qn) should be used for maintaining the serum drug concentrations at 5~10 μg·ml -1 .

More abstracts about the Serum drug concentration in patients treated with various aminophylline regimens
Please Rate this abstract : 1 2 3 4 5


Add your comment No comments

Comments & Reviews about Serum drug concentration in patients treated with various aminophylline regimens Article Abstract

Read Free Summaries - Write and Get Paid

Summarize Human Knowledge on Shvoong. Join us!

------